Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Ophthalmology|August 11, 2015
The Association of Race With Childhood UveitisSheila T Angeles-Han, Courtney McCracken, Steven Yeh, et al.
Eye (London, England)|November 30, 2018
Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitisCourtney McCracken, Steven Yeh, Kirsten Jenkins, et al.
Eclinicalmedicine|June 24, 2022
Ophthalmic sequelae and psychosocial impact in pediatric ebola survivorsJessica G Shantha, Dominick Canady, Caleb Hartley, et al.
Ocular Immunology and Inflammation|February 16, 2022
S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitisSheila T Angeles-Han, Virginia Miraldi Utz, Sherry Thornton, et al.
Arthritis Care & Research|June 4, 2015
Using the Effects of Youngsters' Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With UveitisSheila T Angeles-Han, Steven Yeh, Courtney McCracken, et al.
Ocular Immunology and Inflammation|September 10, 2024
Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort StudyIlaria Maccora, Jared J Ebert, Grant S Schulert, et al.
The Journal of Rheumatology|February 17, 2016
Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American ChildrenLauren Fitzpatrick, K Alaine Broadaway, Lori Ponder, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 24, 1998
Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathwayA C Maroney, M A Glicksman, A N Basma, et al.
The Journal of Biological Chemistry|April 28, 2001
Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase familyA C Maroney, J P Finn, T J Connors, et al.
Ocular Immunology and Inflammation|November 25, 2024
Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid UseIlaria Maccora, Mekibib Altaye, Kenneth D Greis, et al.
Pageof 7